Numerous previous reports have shown that inhibition of the PI3K/AKT pathways radiosensitize gliomas (13,15,32,33), consistently with the activation of PI3K/AKT conferring radioresistance (7). The gene discussed is AKT1; the disease is central nervous system cancer.